EVOLUS, INC. Notes Payable, Noncurrent
EVOLUS, INC. (EOLS) had Notes Payable, Noncurrent of $17.95 million as of 2019-12-31, per its 10-K filed 2020-02-25.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Notes Payable, Noncurrent
us-gaap:LongTermNotesPayable · last filed 2020-02-25
- 2019-12-31: Notes Payable, Noncurrent $17.95M.
- 2019-09-30: Notes Payable, Noncurrent $17.67M.
- 2019-06-30: Notes Payable, Noncurrent $17.41M.
- 2019-03-31: Notes Payable, Noncurrent $17.15M.
| Period end | Notes Payable, Noncurrent | Notes Payable, Noncurrent as first filed |
|---|---|---|
| 2019-12-31 | $17.95M 10-K · filed 2020-02-25 | |
| 2019-09-30 | $17.67M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $17.41M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $17.15M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $16.90M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $16.79M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $16.47M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $16.15M 10-Q · filed 2018-05-10 | |
| 2018-02-12 | $16.04M 10-K · filed 2020-02-25 | $16.15M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |